Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoB
18/7 16:02
Company Announcement COPENHAGE N , Denmark ; July 18 , 2022 – Genmab A/S (Nasdaq: GMAB) today announced that AbbVie ( NYSE: ABBV) will submit a conditional marketing authorization application (MAA) with the European Medicines Agency (EMA) for subcutaneous epcoritamab (DuoBody®-CD3xCD20), an...